Eye drop to slow myopia in children
Part of Eyes & vision clinical trials.
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 12 years old.
- They must have mild to moderate nearsightedness (myopia) in both eyes, with a prescription between -1.00 and -4.00 diopters.
- They cannot have any serious eye diseases, like a lazy eye or crossed eyes, or have used other myopia treatments before.
- They must be in good general health, with no allergies to the study drug or eye exam drops.
- You and your child must agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This trial tests if brimonidine eye drops can slow down worsening nearsightedness (myopia) in children aged 6 to 14. If your child has mild to moderate myopia and no other eye problems, they may be able to join.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This study tests two types of special glasses (MiYOSMART) for children with nearsightedness (myopia). The aim is to see how well they slow the progression of myopia while being comfortable and safe to wear.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.